Further evaluation of patients with autosomal-dominant and sporadic KFS by genetic testing, biochemical measurements, such as plasma TGF-β1, and systematic follow-up EMG seems warranted. This evidence concerns the gene TGFB1 and Klippel-Feil syndrome 1, autosomal dominant.